Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary
Compounding Law; Health Care; Awareness of all Types of Compounding Issues;
Pharmacy Benefit Managers (PBMs), Outsourcing Facilities
Food and Drug Administration and Compliance Issues
Wednesday, February 22, 2017
Second Question of the Day February 22, 2017 Current Federal Statutory Law does not address and many argue it does not permit compounding of animal drugs from bulk drug substances. The FDA, however, has previously recognized that there are limited circumstances when an animal drug compounded from bulk drug substances may be an appropriate treatment option. This recognition has been done in FDA guidance (see draft “Guidance for Industry (GFI) #230, Compounding Animal Drugs from Bulk Drug Substances.” ). With President Trump's executive order limiting regulations what does this mean for the future of animal drug compounding?